Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of INDEX PHARM. AB AK B
No Price
Closing Price XSTO 29.04.2026:
26,80 SEK
29.04.2026 11:03
Current Prices from INDEX PHARM. AB AK B
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ STOCKHOLM AB
FLERIE.ST
SEK
29.04.2026 11:03
26,80 SEK
-0,60 SEK
-2,19 %
Share Float & Liquidity
Free Float19,28 %
Shares Float16,04 M
Shares Outstanding83,22 M
Company Profile for INDEX PHARM. AB AK B Share
InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis. The company's lead drug candidate is Cobitolimod, which is in phase III clinical development for the treatment of patients with moderate to severe ulcerative colitis. It also develops a portfolio of other DNA based immunomodulatory sequences in preclinical stage for the treatment of various immunological diseases. The company was founded in 2000 and is headquartered in Solna, Sweden.
